Key facts
- Percipio Health’s last known valuation is $3.0M (Feb 2023).
- It has raised $21.0M across 2 recorded rounds; the latest was Early Stage VC ($11.5M) in May 2024.
- Notable investors include Flare Capital Partners, Labcorp Venture Fund, First Trust Capital Partners, UPMC Enterprises, FortySix Capital — 8 tracked in total.
- Percipio Health has filed 3 Form Ds with the SEC since 2022, most recently May 2024 ($11.5M sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Percipio Health
Funding rounds
2 roundsAbout Percipio Health
Developer of health monitoring and management software intended to support healthcare organizations in managing rising patient populations. The company's software is designed for health systems and payers and offers tools for continuous population-level health monitoring, risk stratification, workflow support, and data-driven decision assistance that fit within evolving clinical decision support regulations, enabling healthcare enterprises to improve outcomes, target interventions more effectively, and modernize digital health strategies.
- Sector
- Healthcare
- HQ
- Plano, TX, United States
- Founded
- 2022
- Employees
- 43
- Website
- percipiohealth.com/
- Ownership
- Privately Held (backing)
Percipio Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Percipio Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Percipio Health in its N-PORT filings yet. We sweep new filings monthly.